CWM
ZBH icon

Cranbrook Wealth Management’s Zimmer Biomet ZBH Stock Holding History

Cranbrook Wealth Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-25
Closed -$4K – 277
2019
Q4 		$4K Hold
25
– – ﹤0.01% 232
2019
Q3 		$3K Buy
+25
New +$3.23K ﹤0.01% 239

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cranbrook Wealth Management's ZBH Position: Q1 2020 in Review

Cranbrook Wealth Management sold out of Zimmer Biomet (ZBH) in Q1 2020, closing a stake of 25 shares — an estimated $4K sold.

Cranbrook Wealth Management first reported a position in ZBH in Q3 2019 and held it in 2 quarters. The position peaked at $4K in Q4 2019. 883 funds tracked by Wall St. Rank hold ZBH as of Q1 2020.

  • Cranbrook Wealth Management reported no remaining Zimmer Biomet position as of Q1 2020 after selling out during the quarter.
  • Cranbrook Wealth Management sold 25 Zimmer Biomet shares in Q1 2020, an estimated $4K.
  • Cranbrook Wealth Management first reported a position in Zimmer Biomet in Q3 2019 and held it in 2 quarters.
  • Cranbrook Wealth Management's Zimmer Biomet position peaked at $4K in Q4 2019.
  • 883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2020.

Based on Cranbrook Wealth Management's 13F filing for Q1 2020, filed 13 May 2020.